Dr. Strouse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Hawkins Dr
Se 636 Gh
Iowa City, IA 52242Phone+1 319-356-4019Fax+1 319-353-8073- Is this information wrong?
Education & Training
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2019 - 2020
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2013 - 2016
- University of Wisconsin School of Medicine & Public HealthClass of 2013
Certifications & Licensure
- IA State Medical License 2016 - 2025
- WI State Medical License 2015 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma Start of enrollment: 2022 Oct 27
Roles: Principal Investigator
- High Dose Ascorbic Acid for Plasma Cell Disorders Start of enrollment: 2019 Mar 05
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.Wancheng Guo, Christopher Strouse, David Mery, Eric R Siegel, Manit N Munshi, Timothy Cody Ashby, Yan Cheng, Fumou Sun, Visanu Wanchai, Zijun Zhang, Clyde Bailey, Dais...> ;Cancers. 2024 Mar 11
- Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzu...Matthew J Maurer, Carla Casulo, Melissa C Larson, Thomas M Habermann, Izidore S Lossos, Yucai Wang, Loretta J Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin...> ;Haematologica. 2023 Nov 30
- Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients.Christopher Strouse, Sarah L Mott, Brian J Smith, Margarida Magalhaes-Silverman, Umar Farooq, Fenghuang Zhan, Yogesh Jethava, Guido Tricot> ;Bone Marrow Transplantation. 2024 Jan 1
- Join now to see all
Abstracts/Posters
- Methotrexate and Area Under the Curve Exposure in Patients Receiving MT-R for Primary CNS Lymphoma: A Single Institution Retrospective StudyChristopher Strouse, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- North American Practice Patterns for PET-2 Positive Hodgkin LymphomaChristopher Strouse, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety a...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
Hospital Affiliations
- University of Iowa Hospitals and ClinicsIowa City, Iowa
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: